Company Filing History:
Years Active: 2017
Title: Wangke Qian: Innovator in Pharmaceutical Compounds
Introduction
Wangke Qian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of innovative drugs related to dopamine and serotonin receptors.
Latest Patents
Wangke Qian holds a patent for a diaryl[A, G]quinolizidine compound, which includes its preparation method, pharmaceutical composition, and various uses. This invention is crucial for creating experimental model drugs that target dopamine receptors and 5-HT receptors. The patent emphasizes the compound's potential in treating or preventing diseases associated with these receptors.
Career Highlights
Throughout his career, Wangke Qian has worked with prominent organizations, including Kingsound & Partner and the Chinese Academy of Sciences. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Wangke Qian has collaborated with esteemed colleagues such as Hong Tao Liu and Xuechu Zhen. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Wangke Qian's innovative work in pharmaceutical compounds showcases his dedication to advancing medical science. His contributions are vital for the development of new treatments for diseases related to dopamine and serotonin receptors.